NeuBase Therapeutics, Inc. Convertible Notes Payable, Noncurrent
NeuBase Therapeutics, Inc. had Convertible Notes Payable, Noncurrent of $892.22 thousand as of 2019-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:ConvertibleLongTermNotesPayable · last filed 2020-05-14
- 2019-03-31: Convertible Notes Payable, Noncurrent $892.22K.
- 2018-12-31: Convertible Notes Payable, Noncurrent $259.61K.
- 2018-09-30: Convertible Notes Payable, Noncurrent $250.00K.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2019-03-31 | $892.22K 10-Q · filed 2020-05-14 |
| 2018-12-31 | $259.61K 10-Q · filed 2020-03-26 |
| 2018-09-30 | $250.00K 10-K · filed 2020-01-10 |